Literature DB >> 16254311

Trastuzumab for early breast cancer raises important issues.

Edward C F Wilson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16254311      PMCID： PMC1273495          DOI： 10.1136/bmj.331.7523.1023-a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Women with early breast cancer to be tested for trastuzumab treatment.

Authors:  Susan Mayor
Journal:  BMJ       Date:  2005-10-15

2.  c-erbB2 and topoisomerase IIalpha protein expression independently predict poor survival in primary human breast cancer: a retrospective study.

Authors:  Peter Fritz; Cristina M Cabrera; Jürgen Dippon; Andreas Gerteis; Wolfgang Simon; Walter E Aulitzky; Heiko van der Kuip
Journal:  Breast Cancer Res       Date:  2005-03-21       Impact factor: 6.466
  2 in total
  1 in total

1.  Media Hyping and the "Herceptin Access Story": An Analysis of Canadian and UK Newspaper Coverage.

Authors:  Julia Abelson; Patricia A Collins
Journal:  Healthc Policy       Date:  2009-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.